HomeNPCE • NASDAQ
add
Neuropace Inc
Previous close
$8.56
Day range
$8.07 - $8.70
Year range
$3.80 - $18.15
Market cap
235.04M USD
Avg Volume
134.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 18.12M | 25.23% |
Operating expense | 20.89M | 11.75% |
Net income | -8.92M | 13.98% |
Net profit margin | -49.24 | 31.32% |
Earnings per share | -0.32 | 21.95% |
EBITDA | -7.50M | 9.32% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 58.94M | -12.82% |
Total assets | 98.85M | -6.98% |
Total liabilities | 84.51M | 7.27% |
Total equity | 14.34M | — |
Shares outstanding | 28.77M | — |
Price to book | 17.12 | — |
Return on assets | -18.27% | — |
Return on capital | -20.90% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.92M | 13.98% |
Cash from operations | -7.53M | 22.38% |
Cash from investing | 2.40M | -76.20% |
Cash from financing | 72.00K | 128.24% |
Net change in cash | -5.06M | -4,500.00% |
Free cash flow | -7.95M | -7.95% |
About
Founded
1997
Website
Employees
171